American PeptidesRetatrutide
Ordered Retatrutide from American Peptides? Mail in a sample (US only) and let us test it.
Test my supplyAmerican Peptides' Retatrutide record is mixed because a recent no-label 20 mg vial failed identity, though endotoxins were negative. The 99.9% near-fill passes before and after help, but the small, volatile set leaves uncertainty.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including American Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 6 Nov 2026 | Pass | fv56fue Tested | lab name | View COA | |||
| 2 Nov 2026 | Fail | 4mvnfqv Tested | lab name | View COA | |||
| 30 Sep 2026 | Pass | 2qw5hj8 Tested | lab name | View COA | |||
About American Peptides test results from Finnrick
American Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 3 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible American Peptides peptides in this dataset are Retatrutide (3 tests), BPC-157 (0 tests) and TB-500 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 3 recent tests.
Ordered Retatrutide from American Peptides? Mail in a sample (US only) and let us test it.
Test my supply